Page last updated: 2024-10-28

glipizide and Hyperglycemia, Postprandial

glipizide has been researched along with Hyperglycemia, Postprandial in 23 studies

Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.

Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.

Research Excerpts

ExcerptRelevanceReference
" In the present study, the effects of sulfonylureas administered supraspinally on kainic acid (KA)-induced hippocampal neuronal cell death and hyperglycemia were studied in ICR mice."7.80Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice. ( Jung, JS; Kim, CH; Kim, SJ; Kim, SS; Lim, SM; Park, SH; Sim, YB; Suh, HW, 2014)
"Control of glycemia was classified and monitored and serum fructosamine and blood GHb concentrations were measured for 12 poorly controlled diabetic cats before and after improving glycemic control, 8 well-controlled treated diabetic cats before and after glycemic control deteriorated, and 5 cats with diabetes mellitus before and after onset of stress-induced hyperglycemia."7.70Comparison of serum fructosamine and blood glycosylated hemoglobin concentrations for assessment of glycemic control in cats with diabetes mellitus. ( Elliott, DA; Feldman, EC; Neal, LA; Nelson, RW; Reusch, CE, 1999)
"Alogliptin monotherapy maintained glycaemic control comparable to that of glipizide in elderly patients with T2DM over 1 year of treatment, with substantially lower risk of hypoglycaemia and without weight gain."5.17Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double-blind, randomized, 1-year study. ( Fleck, P; Rosenstock, J; Wilson, C, 2013)
"This study was designed to compare the efficacy of acute premeal administration of glipizide versus nateglinide in controlling postprandial hyperglycemia in subjects with non-insulin-requiring type 2 diabetes."5.10Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues. ( Burge, MR; Carroll, MF; Izard, A; Riboni, K; Schade, DS, 2002)
" In the present study, the effects of sulfonylureas administered supraspinally on kainic acid (KA)-induced hippocampal neuronal cell death and hyperglycemia were studied in ICR mice."3.80Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice. ( Jung, JS; Kim, CH; Kim, SJ; Kim, SS; Lim, SM; Park, SH; Sim, YB; Suh, HW, 2014)
"Control of glycemia was classified and monitored and serum fructosamine and blood GHb concentrations were measured for 12 poorly controlled diabetic cats before and after improving glycemic control, 8 well-controlled treated diabetic cats before and after glycemic control deteriorated, and 5 cats with diabetes mellitus before and after onset of stress-induced hyperglycemia."3.70Comparison of serum fructosamine and blood glycosylated hemoglobin concentrations for assessment of glycemic control in cats with diabetes mellitus. ( Elliott, DA; Feldman, EC; Neal, LA; Nelson, RW; Reusch, CE, 1999)
" Rats were given a subcutaneous injection of 1 g/kg glucosamine: this dose caused marked hyperglycemia and a decrease in hepatic glycogen, but does not alter blood insulin levels."3.66Glipizide and hepatic glycogenolysis. ( Bloch, K; Daturi, S; Tommasini, R, 1980)
"In this study, 148 patients with type 2 diabetes mellitus (T2DM) were assigned randomly to receive either glipizide alone or glipizide plus Aralia root bark extract (ARBE) for 8 weeks to test the effects of ARBE plus glipizide therapy on glycemic control and lipid profiles in these patients."2.80Effects of combined therapy with glipizide and Aralia root bark extract on glycemic control and lipid profiles in patients with type 2 diabetes mellitus. ( Fang, XF; Han, CC; Li, XM; Liu, XH; Ma, L, 2015)
" The decision to prescribe one of these three insulinotropic agents should be based on factors such as the patient's ability to comply with complex dosing regimens, the need to control fasting hyperglycemia, the risk of interprandial hypoglycemia, and pharmacoeconomic considerations, rather than postprandial glucose-lowering efficacy."2.71Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes. ( Carroll, MF; Castro, M; Gutierrez, A; Schade, DS; Tsewang, D, 2003)
" This delay of absorption may be clinically relevant, since the efficacy of short-acting sulphonylureas is dependent upon the absorption rate of the drug."2.66Hyperglycaemia and absorption of sulphonylurea drugs. ( DeFronzo, RA; Groop, LC; Luzi, L; Melander, A, 1989)
"In patients with type 1 diabetes mellitus a quality of life decreases gradually with the duration of diabetes."2.41[The effect of improved glycemic control on quality of life in patients with type I and type II diabetes]. ( Grzeszczak, W, 2001)
"The quality of life of NIDDM patients can be improved by stricter glycaemic control, and thus can modify in the choice of therapeutic strategies and cost-benefit evaluation of intensive glycaemic control."2.40[Quality of life and non-insulin-dependent diabetes]. ( Tauber, JP, 1997)
" In this work, enhancement of the solubility and dissolution of the practically insoluble drug glipizide was achieved by formation of bionanocomposites (BNCs) using microwave-induced diffusion (MIND), which ultimately leads to bioavailability enhancement."1.39Microwave-generated bionanocomposites for solubility and dissolution enhancement of poorly water-soluble drug glipizide: in-vitro and in-vivo studies. ( Gattani, SG; Kushare, SS, 2013)
"During the hyperglycemic clamp in NIDDM subjects, the first-phase plasma insulin response was absent, and the second-phase insulin response was markedly impaired."1.27Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. ( DeFronzo, RA; Groop, L; Groop, PH; Luzi, L; Melander, A; Ratheiser, K; Simonson, DC, 1987)

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19905 (21.74)18.7374
1990's6 (26.09)18.2507
2000's6 (26.09)29.6817
2010's5 (21.74)24.3611
2020's1 (4.35)2.80

Authors

AuthorsStudies
Schindler, MSZ1
Calisto, JFF1
Marins, K1
Regginato, A1
Mezzomo, H1
Zanatta, AP1
Radunz, AL1
Mariot, MP1
Dal Magro, J1
Zanatta, L1
Campbell, JM1
Adanichkin, N1
Kurmis, R1
Munn, Z1
Rosenstock, J1
Wilson, C1
Fleck, P1
Kim, CH1
Park, SH1
Sim, YB1
Kim, SS1
Kim, SJ1
Lim, SM1
Jung, JS1
Suh, HW1
Liu, XH1
Li, XM1
Han, CC1
Fang, XF1
Ma, L1
Kushare, SS1
Gattani, SG1
Carroll, MF2
Izard, A1
Riboni, K1
Burge, MR1
Schade, DS2
Gutierrez, A1
Castro, M1
Tsewang, D1
Vähätalo, M1
Rönnemaa, T1
Viikari, J1
Kapoor, JR1
Bloch, K1
Daturi, S1
Tommasini, R1
Esmatjes, E1
Vinuesa, P1
Navarro, P1
Rodriguez-Villar, C1
Gomis, R1
Vilardell, E1
Schmitz, O1
Lund, S1
Bak, JF1
Orskov, L1
Andersen, PH1
Møller, N1
Rasmussen, O1
Christiansen, JS1
Pedersen, O1
Jaber, LA1
Lewis, NJ1
Slaughter, RL1
Neale, AV1
Tauber, JP1
Elliott, DA1
Nelson, RW1
Reusch, CE1
Feldman, EC1
Neal, LA1
Martin, G1
Rand, J1
Grzeszczak, W1
Pasmantier, R1
Chaiken, RL1
Hirsch, SR1
Lebovitz, HE1
Groop, LC1
Luzi, L2
DeFronzo, RA2
Melander, A3
Bitzén, PO1
Scherstén, B1
Wåhlin-Boll, E1
Groop, L1
Groop, PH1
Ratheiser, K1
Simonson, DC1
Cederholm, J1
Wibell, L1

Reviews

4 reviews available for glipizide and Hyperglycemia, Postprandial

ArticleYear
Intensive insulin therapy, insulin sensitisers and insulin secretagogues for burns: A systematic review of effectiveness and safety.
    Burns : journal of the International Society for Burn Injuries, 2018, Volume: 44, Issue:6

    Topics: Burns; Dipeptidyl-Peptidase IV Inhibitors; Disease Management; Exenatide; Glipizide; Humans; Hypergl

2018
[Quality of life and non-insulin-dependent diabetes].
    Diabetes & metabolism, 1997, Volume: 23 Suppl 4

    Topics: Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; France; Glipizide; Humans; Hyperglycemia;

1997
Current understanding of feline diabetes: part 2, treatment.
    Journal of feline medicine and surgery, 2000, Volume: 2, Issue:1

    Topics: Animals; Blood Glucose; Body Weight; Cat Diseases; Cats; Diabetes Complications; Diabetes Mellitus;

2000
[The effect of improved glycemic control on quality of life in patients with type I and type II diabetes].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2001, Volume: 54, Issue:11-12

    Topics: Adaptation, Psychological; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glipizide; Humans;

2001

Trials

8 trials available for glipizide and Hyperglycemia, Postprandial

ArticleYear
Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double-blind, randomized, 1-year study.
    Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:10

    Topics: Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitor

2013
Effects of combined therapy with glipizide and Aralia root bark extract on glycemic control and lipid profiles in patients with type 2 diabetes mellitus.
    Journal of the science of food and agriculture, 2015, Mar-15, Volume: 95, Issue:4

    Topics: Antioxidants; Aralia; China; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dietary Supplemen

2015
Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
    Diabetes care, 2002, Volume: 25, Issue:12

    Topics: C-Peptide; Cross-Over Studies; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glipizide; Huma

2002
Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:11

    Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Delayed-Action Preparations

2003
Recognition of fasting or overall hyperglycaemia when starting insulin treatment in patients with type 2 diabetes in general practice.
    Scandinavian journal of primary health care, 2007, Volume: 25, Issue:3

    Topics: Administration, Oral; Adult; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Therap

2007
The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy.
    Journal of clinical pharmacology, 1993, Volume: 33, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Femal

1993
Metabolic effects of combination glipizide and human proinsulin treatment in NIDDM.
    Diabetes care, 1990, Volume: 13 Suppl 3

    Topics: Administration, Oral; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug The

1990
Hyperglycaemia and absorption of sulphonylurea drugs.
    Lancet (London, England), 1989, Jul-15, Volume: 2, Issue:8655

    Topics: Adult; Blood Glucose; Dose-Response Relationship, Drug; Drug Evaluation; Female; Gastric Emptying; G

1989

Other Studies

11 other studies available for glipizide and Hyperglycemia, Postprandial

ArticleYear
Characterization of the chemical profile and the effects of ethanolic extracts of Maytenus ilicifolia Mart. ex Reissek on glucose metabolism in normal hyperglycemic rats.
    Journal of ethnopharmacology, 2021, Aug-10, Volume: 276

    Topics: Alanine Transaminase; Animals; Blood Glucose; Disaccharides; Ethanol; Glipizide; Glucose; Glycogen;

2021
Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
    Brain research, 2014, May-20, Volume: 1564

    Topics: Animals; Blood Glucose; CA3 Region, Hippocampal; Cell Death; Glipizide; Glyburide; Hyperglycemia; Hy

2014
Microwave-generated bionanocomposites for solubility and dissolution enhancement of poorly water-soluble drug glipizide: in-vitro and in-vivo studies.
    The Journal of pharmacy and pharmacology, 2013, Volume: 65, Issue:1

    Topics: Animals; Biological Availability; Chemistry, Pharmaceutical; Diffusion; Drug Delivery Systems; Drug

2013
Postprandial hyperglycemia: are all sulfonylureas created equal?
    The American journal of cardiology, 2008, Feb-15, Volume: 101, Issue:4

    Topics: Carbamates; Cyclohexanes; Glipizide; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Na

2008
Glipizide and hepatic glycogenolysis.
    Acta endocrinologica. Supplementum, 1980, Volume: 239

    Topics: Adrenalectomy; Animals; Blood Glucose; Dose-Response Relationship, Drug; Glipizide; Glucosamine; Hyp

1980
The effect of hyperglycemia on glipizide absorption in NIDDM patients.
    Diabetes care, 1995, Volume: 18, Issue:7

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glipizide; Glucose; Humans; Hyperglycemia; Hypogly

1995
Effects of glipizide on glucose metabolism and muscle content of the insulin-regulatable glucose transporter (GLUT 4) and glycogen synthase activity during hyperglycaemia in type 2 diabetic patients.
    Acta diabetologica, 1994, Volume: 31, Issue:1

    Topics: Adult; Biopsy; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glipizi

1994
Comparison of serum fructosamine and blood glycosylated hemoglobin concentrations for assessment of glycemic control in cats with diabetes mellitus.
    Journal of the American Veterinary Medical Association, 1999, Jun-15, Volume: 214, Issue:12

    Topics: Animals; Blood Glucose; Cat Diseases; Cats; Cohort Studies; Diabetes Mellitus; Fructosamine; Glipizi

1999
The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia.
    European journal of clinical pharmacology, 1988, Volume: 35, Issue:1

    Topics: Aged; Biological Availability; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glipizid

1988
Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
    Diabetes, 1987, Volume: 36, Issue:11

    Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Gl

1987
The impact of treatment on insulin release and relative peripheral resistance during the oral glucose tolerance test. A study of noninsulin-dependent diabetes mellitus and glucose intolerance.
    Diabete & metabolisme, 1986, Volume: 12, Issue:1

    Topics: Administration, Oral; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Exercise Therapy; Female; Glip

1986